BlackRock UK A Inc |
| Performance History | 31/08/2010 |
| Growth of 1,000 (GBP) | Advanced Graph |
| Fund | 18.2 | 8.1 | -36.7 | 33.2 | -2.5 | |
| +/-Cat | 2.3 | 3.3 | -4.0 | 3.6 | -4.1 | |
| +/-Idx | 6.6 | -6.0 | -7.4 | 0.6 | -4.4 | |
| Category: UK Large-Cap Growth Equity | ||||||
| Index: MSCI UK Growth NR USD | ||||||
| Trailing Returns | 07/09/2010 |
| YTD | 1.71 |
| 3 Years Annualised | -3.56 |
| 5 Years Annualised | 3.28 |
| 10 Years Annualised | 3.39 |
| 12 Month Yield | 2.02 | |
| Tax Year Return | 54.67 | |
| Dividend Paying Frequency | Annually |
| Benchmarks |
| Fund Benchmark |
| FTSE AllSh TR GBP |
| Morningstar Benchmark |
| MSCI UK Growth NR USD |
| Key Stats | ||
| Morningstar Qualitative Rating™ | ![]() Elite Superior Standard Inferior Impaired | |
| Morningstar Rating™ | ![]() | |
| Morningstar Category™ | UK Large-Cap Growth Equity | |
| IMA Sector | UK All Companies | |
| ISIN | GB0005773881 | |
| NAV 07/09/2010 | GBX 238.10 | |
| Day Change | -0.79% | |
| Fund Size (Mil) 30/07/2010 | GBP 602.55 | |
| Share Class Size (Mil) - | - | |
| Max Initial Charge | 5.00% | |
| Total Expense Ratio 12/12/2009 | 1.65% | |
| Deferred Load | - | |
| Max Exit Charge | - | |
| Inception Date | 11/11/1993 | |
Manager Name Start Date | ||
Mark Lyttleton 01/10/1999 | ||
*
This rating and report were issued for a different share class of this fund. The performance and fee structure of this class may vary from that referenced. | ||
| Investment Objective: BlackRock UK A Inc |
| To achieve long-term capital growth for investors. The Fund invests primarily in the shares of larger companies incorporated or listed in the UK. The Fund may also invest in collective investment schemes. |
| Portfolio Profile for BlackRock UK A Inc | 31/05/2010 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| Top 5 Holdings | Sector | % |
HSBC Holdings PLC | Financial Services | 6.38 |
Rio Tinto PLC | Industrial Materials | 4.70 |
Vodafone Group PLC | Telecommunications | 4.31 |
BP Plc | Energy | 4.01 |
GlaxoSmithKline PLC | Healthcare | 3.80 |
Increase Decrease New since last portfolio | ||
| Growth Of 1000 (GBP) | 31/08/2010 |
|
| Annual Returns | 31/08/2010 | |||||||
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 31/08 | |
| Total Return | 24.38 | 19.81 | 23.11 | 18.24 | 8.15 | -36.71 | 33.22 | -2.52 |
| +/- Category | 6.28 | 9.08 | 2.65 | 2.29 | 3.28 | -3.98 | 3.62 | -4.14 |
| +/- Index | 14.41 | 13.42 | 1.86 | 6.59 | -6.03 | -7.41 | 0.63 | -4.43 |
| % Rank in Category | 13 | 3 | 15 | 21 | 25 | 91 | 26 | 76 |
| Trailing Returns | 07/09/2010 | ||
|
Total Returns | +/- Category | +/- Index | |
| 1 Day | -0.79 | 0.00 | -0.11 |
| 1 Week | 4.34 | 0.04 | 1.03 |
| 1 Month | -1.04 | -1.21 | -3.24 |
| 3 Months | 4.55 | -2.21 | -3.31 |
| 6 Months | -2.35 | -4.08 | -2.15 |
| YTD | 1.71 | -3.91 | -3.57 |
| 1 Year | 10.67 | -5.24 | -9.57 |
| 3 Years Annualised | -3.56 | -4.08 | -5.60 |
| 5 Years Annualised | 3.28 | -1.95 | -2.31 |
| 10 Years Annualised | 3.39 | 0.86 | 2.34 |
| Category: UK Large-Cap Growth Equity | |||
| Index: MSCI UK Growth NR USD | |||
| Quarterly Returns | 31/08/2010 | |||
| Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
| 2010 | 6.75 | -12.28 | - | - |
| 2009 | -8.05 | 17.54 | 19.45 | 3.20 |
| 2008 | -7.49 | 2.34 | -21.05 | -15.33 |
| 2007 | 1.99 | 3.06 | 0.00 | 2.88 |
| 2006 | 10.49 | -2.82 | 2.68 | 7.25 |
| 2005 | 2.70 | 3.11 | 10.20 | 5.50 |
| Morningstar Rating™(Relative to Category) | 31/08/2010 | ||||||||||||||||||||
| |||||||||||||||||||||
| Category : UK Large-Cap Growth Equity | Click here to see our Methodology | ||||||||||||||||||||
| Volatility Measurements | 31/08/2010 | ||||||||
| |||||||||
| Modern Portfolio Statistics | 31/08/2010 | |
| Standard Index | Best Fit Index | |
| MSCI UK Growth NR USD | MSCI Nordic Countries Small Cap NR USD | |
| 3-Yr R-Squared | 85.74 | 91.29 |
| 3-Yr Beta | 1.11 | 0.67 |
| 3-Yr Alpha | -3.86 | -4.19 |
| Investment Style Details | 31/05/2010 | ||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
| Category: UK Large-Cap Growth Equity | |||||||||||||||||||||||||||||||||||||||||
| Asset Allocation | 31/05/2010 |
| ||||||||||||||||||||||||||
| World Regions | 31/05/2010 | ||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
| Category: UK Large-Cap Growth Equity | |||||||||||||||||||||||||||||||||||||||||||
| Sector Weightings | 31/05/2010 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Category: UK Large-Cap Growth Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Top 10 Holdings | 31/05/2010 |
| Portfolio | |
| Total Number of Equity Holdings | 59 |
| Total Number of Bond Holdings | 0 |
| Assets in Top 10 Holdings | 39.68 |
| Name | Sector | Country | % of Assets | ||
HSBC Holdings PLC | ![]() | United Kingdom | 6.38 | ||
Rio Tinto PLC | ![]() | United Kingdom | 4.70 | ||
Vodafone Group PLC | ![]() | United Kingdom | 4.31 | ||
BP Plc | ![]() | United Kingdom | 4.01 | ||
GlaxoSmithKline PLC | ![]() | United Kingdom | 3.80 | ||
Royal Dutch Shell PLC B | ![]() | United Kingdom | 3.68 | ||
Tullow Oil PLC | ![]() | United Kingdom | 3.55 | ||
Tesco PLC | ![]() | United Kingdom | 3.17 | ||
Imperial Tobacco Group PLC | ![]() | United Kingdom | 3.11 | ||
BG Group PLC | ![]() | United Kingdom | 2.97 | ||
Increase Decrease New since last portfolio | |||||
| Category: UK Large-Cap Growth Equity | |||||
| Management | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| Biography | |
| Mark Lyttleton Managing Director and portfolio manager is a member of BlackRock's UK Equity team. Mr Lyttleton joined BlackRock following the merger with Merrill Lynch Investment Managers (MLIM) in 2006. At MLIM he was responsible for managing a range of retail portfolios for the UK equity team and also covered the transport and food producer sectors. He began his investment career at MLIM in 1992. Mr Lyttleton earned a Bsc degree, with honours, in Chemistry, from the University of York in 1992. |
| Fees and Expenses | ||||||||||||||||
| ||||||||||||||||
| Purchase Details | ||||||||
| ||||||||
| ||||||||












Telecommunications
Healthcare
Increase
New since last portfolio

Information
Software
Hardware
Media
Service
Business Services
Manufacturing
Utilities